コネチカット州における潰瘍性大腸炎の臨床試験
コネチカット州内の拠点で、潰瘍性大腸炎に関する11件の研究が参加者を募集しています。
コネチカット州内の都市
公式研究テキスト（英語）
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Medical Research Center of Connecticut, LLC, Hamden
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT06598943A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-028, Bristol
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07845487A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Connecticut Children's Medical Center, Hartford
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT07196748Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Connecticut Children's Medical Center, Hartford
被験者募集中第3相
2歳〜19歳 · 全性別 · 2026/09/22更新 · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Medical Research Center of Connecticut, Hamden
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07415044Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- Connecticut Clinical Research Institute ( Site 0297), Bristol
被験者募集中第3相
全年齢 · 全性別 · 2026/09/09更新 · NCT06651281An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Yale University Digestive Disease - Site Number: 8400108, New Haven
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Yale University, New Haven
被験者募集中
18歳以上 · 全性別 · 2026/08/07更新 · NCT05230173Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Yale University School of Medicine, New Haven
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/05更新 · NCT07237516Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
- Connecticut Children's Medical Center, Hartford
被験者募集中観察研究健康なボランティア歓迎
10歳〜21歳 · 全性別 · 2026/07/16更新 · NCT07224113ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。